HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies against cancer and chronic infectious diseases. They pioneer an arenavirus platform to reprogram the immune system, inducing robust T cell responses and neutralizing antibodies. Their technology engineers arenaviruses for therapeutic purposes, achieving T cell response levels unmatched by other approaches. As a global company, they advance a diverse pipeline and partner with key organizations.
Registre Officiel
Analyse Qualité IA
Détails du Score de Confiance
Liens Rapides
Points forts du site
🌟 Entreprises similaires de confiance
Kalaris Therapeutics, Inc.
Kalaris is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases. They focus on innovative retinal treatments, including TH103, a potential best-in-class anti-VEGF agent for neovascular AMD. Kalaris aims to ease patient burden and improve outcomes in retinal disease management.
ALX ONCOLOGY HOLDINGS INC
ALX Oncology is a clinical-stage biopharmaceutical company advancing therapies that boost the immune system to treat cancer. Their lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. They focus on developing novel approaches to optimize current and future standards of cancer care.
PUMA BIOTECHNOLOGY, INC.
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. They focus on in-licensing innovative drug candidates that have undergone clinical testing. Puma Biotechnology aims to improve cancer treatment through innovative drug development.